Original Article
Copyright ©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Jun 28, 2012; 18(24): 3089-3098
Published online Jun 28, 2012. doi: 10.3748/wjg.v18.i24.3089
Table 1 Patient characteristics
CharacteristicsG + E group (n = 31)G group (n = 30)P
Age (yr)50.7 ± 1.846.9 ± 1.50.4161
Gender (male/female)4/278/220.2112
Hepatitis history (yes/no)5/266/240.7492
AFP ( ≤ 20 ng/mL/> 20 ng/mL)13/1814/160.7992
Liver cirrhosis (Yes/no)10/217/230.5702
ALT ( ≤ 40 U/L/> 40 U/L)18/1311/190.7952
Child-Pugh Score (A/B)2/292/281.0002
Tumor differentiation (I-II/III-IV)7/249/210.5702
Tumor size ( ≤ 5 cm/> 5 cm)8/237/231.0002
Tumor number (single/multiple)8/235/250.5342
Tumor encapsulation (complete/none)12/1915/150.4442
Vascular invasion (no/yes)6/258/220.5542
Blood loss ( ≤ 200 mL/> 200 mL)1/304/260.1952
Anesthesia time ( ≤ 3 h/> 3 h)18/139/210.4262
VAS score3.58 ± 0.323.67 ± 0.380.8631
Dose of fentanyl (μg)0.30 ± 0.010.51 ± 0.01< 0.0011
Dose of morphine (mg)2.26 ± 0.0895.30 ± 1.17< 0.0011
Dose of sevoflurane (mL)21.74 ± 0.7037.90 ± 1.60< 0.0011